MedTrace Logo

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

NCT03327103 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 316

Last updated 2020-10-28

No results posted yet for this study

Summary

Prostate cancer is a commonly diagnosed cancer, and is the second leading cause of cancer deaths among men in the U.S. The subgroup of men with advanced prostate cancer is particularly vulnerable to difficult choices for treatment because of the nature of their disease and having limited options. This study will test the use of an innovative Registered Nurse-Community Patient Navigator team delivered interactive mHealth decision aid for patients with advanced prostate cancer to help facilitate informed shared decisions about anti-cancer treatment that affects their quality of life.

Conditions

  • Decision Support Techniques

Interventions

BEHAVIORAL

CHAMPION

An interactive mHealth decision aid that includes immediate and over time quality of life (QL) graphical summaries for advanced prostate cancer patients to enhance informed, shared decision making and will also be used to assess the CPNs' role in the decision-making process.

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • Virginia Commonwealth University

    collaborator OTHER

  • University of Virginia

    lead OTHER

Principal Investigators

  • Randy A Jones, PhD,RN,FAAN · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-21
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03327103 on ClinicalTrials.gov